SAN CARLOS, Calif.–(BUSINESS WIRE)–BioCardia®, Inc. (OTC:BCDA) today announced publication of a study in the International Heart Journal.1 According to the study, delivery of stem cell therapy to the heart using the Helix™transendocardial delivery system results in superior cell delivery than […]